Leishmaniasis, Cutaneous: Clinical Trials

4 trials for Leishmaniasis, Cutaneous, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Terminated 4
Phase 21Terminated 1

Follow Leishmaniasis, Cutaneous: new trials by email Literature Review of Leishmaniasis, Cutaneous trials Research Report on Leishmaniasis, Cutaneous

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan
HECT-CL - Cutaneous Leishmaniases
Phase 3TerminatedMedecins Sans Frontieres, Netherlands562017-10-042019-01-16
High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus
Fluconazole, Meglumine Antimoniate - Cutaneous Leishmaniasis
Phase 3TerminatedHospital Universitário Professor Edgard Santos532014-02-012015-12-02
Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis
Glucantime®, Zithromax ® - Cutaneous Leishmaniasis
Phase 2 / Phase 3TerminatedAna Rabello482008-06-012014-10-17
Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
controlled nitric oxide releasing patch, meglumine antimoniate - Cutaneous Leishmaniasis
Phase 3TerminatedFundación Cardiovascular de Colombia1782006-05-012010-11-24

Narrower conditions

Hyperthermia (1)  ·  Leishmaniasis (1)

Broader conditions

Euglenozoa Infections (4)  ·  Infections (4)  ·  Parasitic Diseases (4)  ·  Protozoan Infections (4)  ·  Skin Diseases (4)  ·  Skin Diseases, Infectious (4)  ·  Skin Diseases, Parasitic (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Vector Borne Diseases (4)  ·  Leishmaniasis (3)  ·  Body Temperature Changes (1)  ·  Heat Stress Disorders (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Wounds and Injuries (1)

Interventions

Meglumine Antimoniate (3)  ·  Azithromycin (1)  ·  Fluconazole (1)

Sponsors

Ana Rabello (1)  ·  Fundación Cardiovascular de Colombia (1)  ·  Hospital Universitário Professor Edgard Santos (1)  ·  Medecins Sans Frontieres, Netherlands (1)

Countries

Brazil (2)  ·  Colombia (1)  ·  Pakistan (1)

Top investigators

Ana Rabello, MD PhD (1)  ·  Christian F Rueda-Clausen, MD (1)  ·  Daniel J Smith, PhD (1)  ·  Daniel Smith, PhD (1)  ·  Federico A Silva, MD (1)  ·  Hernando Mosquera, MD (1)  ·  Isabela Ribeiro, MD (1)  ·  Koert Ritmeijer, PhD (1)  ·  Ligia C Rueda, MD (1)  ·  Paulo Roberto Lima Machado, PhD (1)

Results publications

PMID 27803094